Skip to content
Wenlo
Sign in
← Markets

Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. (BOLT) — Form 8-K: Current report

8-KBOLTFiled Oct 23, 2026, 6:31 AM ET· Period Oct 23, 2026

About this filing

Bolt Biotherapeutics, Inc. (BOLT) filed an 8-K on Oct 23, 2026 reporting entry into a material agreement (Item 1.01), termination of a material agreement (Item 1.02), a completed acquisition or sale of assets (Item 2.01) and 5 more items, with exhibits (Item 9.01).

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

  • Item 1.01 · Entry into a material agreement
  • Item 1.02 · Termination of a material agreement
  • Item 2.01 · Completed acquisition or sale of assets
  • Item 3.02 · Unregistered sale of shares
  • Item 5.02 · Executive or director change or pay arrangement
  • Item 5.03 · Charter, bylaw or fiscal-year change
  • Item 7.01 · Regulation FD disclosure
  • Item 8.01 · Other events
  • Item 9.01 · Financial statements and exhibits

More BOLT filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.